tiprankstipranks
Trending News
More News >
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Income Statement

Compare
83 Followers

bioAffinity Technologies, Inc. Income Statement

Last quarter (Q1 2025), bioAffinity Technologies, Inc.'s total revenue was $1.85M, a decrease of -22.97% from the same quarter last year. In Q1, bioAffinity Technologies, Inc.'s net income was $-2.66M. See bioAffinity Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.36M$ 2.53M$ 4.80K$ 0.00$ 0.00
Gross Profit
$ 3.38M$ 791.62K$ 4.34K$ -4.82K$ -22.24K
Operating Expenses
$ 12.33M$ 8.76M$ 4.02M$ 2.21M$ 2.60M
Depreciation and Amortization
$ 605.64K$ 249.59K$ 10.18K$ 4.82K$ 22.24K
EBITDA
$ -8.33M$ -7.63M$ -5.61M$ -2.20M$ -6.86M
Operating Income
$ -8.95M$ -7.97M$ -4.01M$ -2.21M$ -2.60M
Other Income/Expenses
$ -74.74K$ 57.21K$ -4.14M$ -4.12M$ -4.66M
Pretax Income
$ -9.03M$ -7.92M$ -8.15M$ -6.32M$ -7.27M
Net Income
$ -9.04M$ -7.94M$ -8.15M$ -6.33M$ -7.27M
Per Share Metrics
Basic EPS
$ -0.73$ -0.91$ -1.81$ -0.86$ -0.99
Diluted EPS
$ -0.73$ -0.91$ -1.81$ -0.86$ -0.99
Weighted Average Shares Outstanding
12.13M 8.75M 4.50M 7.38M 7.38M
Weighted Average Shares Outstanding (Diluted)
12.13M 8.75M 4.50M 7.38M 7.38M
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis